VistaGen Therapeutics, Inc.

Historical 13F Holders

Symbol
VTGN
CUSIP
92840H400
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92840H400 since 12/18/2024, largest first.

Filer % of Class Filed
TCG Crossover GP II, LLC 13G/A
10.0% 5/15/2026
Event 3/31/2026
TCG Crossover GP I, LLC 13G/A
6.7% 8/14/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (8)
Great Point Partners, LLC 13G/A
4.95% 2/17/2026
Event 12/31/2025
Nantahala Capital Management, LLC 13G/A
4.7% 2/13/2026
Event 12/31/2025
Vanguard Group Inc 13G/A 4.6% 1/30/2026
Event 12/31/2025
Biotechnology Value Fund L P 13G/A
3.7% 11/16/2026
Event 9/30/2026
Commodore Capital LP 13G/A
3.7% 11/16/2026
Event 9/30/2026
StemPoint Capital LP 13G/A
1.5% 2/17/2026
Event 12/31/2025
Janus Henderson Group PLC 13G/A 0% 2/17/2026
Event 12/31/2025
Orbimed Advisors LLC 13G/A
0% 8/14/2026
Event 6/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 43 10.4 M $3.13M
2026 Q2 53 11.8 M $2.54M
2026 Q1 57 14.7 M $8.12M
2025 Q4 57 13.8 M $8.84M
2025 Q3 58 23.4 M $81.8M
2025 Q2 53 15.5 M $30.3M
2025 Q1 50 15.9 M $39.0M
2024 Q4 56 15.5 M $44.9M
2024 Q3 48 15.3 M $45.3M
2024 Q2 43 13.7 M $47.0M
2024 Q1 42 14.6 M $76.7M
2023 Q4 48 14.9 M $76.2M
2023 Q3 36 3.00 M $15.7M
2023 Q2 33 967 k $1.81M